AGP Executive Report
Last update: 26 minutes agoIndustry Results: Tilray Brands reported record first-quarter fiscal 2027 revenue and gross profit, with year-over-year growth across international cannabis, beverages and pharmaceutical distribution. Federal Policy: State officials are pressing the DEA for cannabis-rescheduling guidance as a December deadline threatens to sharply restrict the hemp-derived THC market, valued at $28 billion. Medical Research: New York regulators approved a trial of oral THC for sciatica-related pain; the University of Regina is studying CBD for concussion, and the FDA opened a conditional-approval pathway for a cannabinoid drug for canine bone-cancer pain. Product Safety: A survey found cannabis consumers said QR-coded products made them feel better protected by regulators. Cannabis Science: New research explores why cannabis can trigger paranoia and anxiety, including the brain cells involved. Hemp Innovation: An Australian couple’s hemp-built home highlights the material’s insulation and fire-resistant properties.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
